Pykus Therapeutics
Cambridge, US · Founded 2016 · Delaware corporation · 12 employees on LinkedIn · 2 known investors
Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery. Its lead product, PYK-2101, is a biodegradable hydrogel intended to help patients recover from retina surgery faster and more comfortably.
Founders & leadership
Pykus Therapeutics was founded in 2016 by James (Tony) Stefater.
J(
James (Tony) StefaterinFounder
JA
James A. StefaterNamed on SEC filing
MS
Michael SingerNamed on SEC filing
RL
Richel LiuNamed on SEC filing
TP
Thomas P. StryjewskiNamed on SEC filing
SS
Sameer SabirNamed on SEC filing
CB
Carl BerkeNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2020
▶$2.5MraisedFeb 2021 · 32 investors · Other Health CareRule 506(b)
▶$2.5MraisedFeb 2021 · 32 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James A. StefaterExecutive Officer
- Michael SingerDirector
- Richel LiuDirector
- Thomas P. StryjewskiDirector
- Sameer SabirDirector
- Carl BerkeDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapAvttx4 shared keywordsAVTTX is a clinical-stage company developing gene therapy treatments for retinal and ophthalmologic diseases. The company leverages adeno-associated virus (AAV) technology to address unmet medical needs in vision care.
Doximity3 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Pykus Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pykus Therapeutics do?
- Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery. Its lead product, PYK-2101, is a biodegradable hydrogel intended to help patients recover from retina surgery faster and more comfortably.
- Who founded Pykus Therapeutics?
- Pykus Therapeutics was founded by James (Tony) Stefater in 2016.
- Who are Pykus Therapeutics's investors?
- Pykus Therapeutics's investors include Beacon Angels, ShangBay Capital LLC.
- How much funding has Pykus Therapeutics raised?
- Pykus Therapeutics has disclosed $2.5M raised across 1 round.
- Where is Pykus Therapeutics headquartered?
- Pykus Therapeutics is headquartered in Cambridge, US.